Core Lithium Ltd (CXO)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 0.200 |
|---|---|
| 52-week range | 0.105 – 0.430 |
| Return, 1 month / 3 months | −45.9% / −16.7% |
| Return, 1 year / 3 years | +81.8% / −42.9% |
| Trend | Below its 200-day average |
| RSI (14) | 24 |
| Volatility (1 year) | 89.0% |
| Worst drawdown (1 year) | -52.4% |
| Average daily value traded | 12.20M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Core Lithium is an Australian mining company focused on lithium. It develops and operates hard rock lithium deposits in the Northern Territory, where it extracts ore and processes it into lithium concentrate, also called spodumene concentrate, for customers in the battery and energy storage supply chain. The company is based in Australia and its main operations centre on the Finniss project near Darwin, which supplies concentrate to buyers overseas.
On this site Core Lithium Ltd appears as a stock on the Australian Securities Exchange (Australia), code CXO, with prices in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Core Lithium Ltd (CXO) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.200 on 19 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 789 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 81.8% and over the last three months it fell 16.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -30.3% | ||
| From 52-week high | -52.4% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.7% | ||
| 6-month return | -41.2% | ||
| 12-month return, skipping the last month | 236.4% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 89.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -52.4% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 12.20M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −13.0% |
|---|---|
| 1 month | −45.9% |
| 3 months | −16.7% |
| 6 months | −41.2% |
| 1 year | +81.8% |
| 3 years | −42.9% |
| 5 years | −64.9% |
Signals
| 50-day / 200-day average | 0.333 / 0.287 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.025 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.